Trial · NCT01507376
Comparing the Efficacy of Urinary and Recombinant Human Chorionic Gonadotropin (hCG) on Oocyte Maturity
NCT01507376, Phase 3, Completed, Royan Institute
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Comparing the Efficacy of Urinary and Recombinant Human Chorionic Gonadotropin (hCG) on Oocyte Maturity. Trials, record NCT01507376. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01507376
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Comparing the Efficacy of Urinary and Recombinant Human Chorionic Gonadotropin (hCG) on Oocyte Maturity
- NCT number
- NCT01507376
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 180 participants, actual
- Lead sponsor
- Royan Institute
- Conditions
- In Vitro Fertilization
- Interventions
- recombinant hCG, recombinant hCG, urinary hCG
- First posted
- 2012-01-10
- Last updated
- 2014-04-25
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of mature oocytes | Up to1 hour after oocyte retrieval | evaluation the effect of recombinant hcg on number of oocytes up to 1 hour after oocytes retrieval |
| Secondary | number of retrieved oocytes per number of aspirated follicles proportion | up to 1 hour after oocyte retrieval | Evaluation the effect of recombinant hCG to retrieve oocytes per number of aspirated follicles proportion |
| Secondary | fertilization rate | in 1 day after oocyte retrieval | Evaluation the effect of recombinant hCG on fertilization rate in 1 day after oocyte retrieval |
| Secondary | implantation rate | 4 weeks after embryo transfer | Evaluation the effect of recombinant hCG on implantation rate 4 weeks after embryo transfer |
| Secondary | OHSS occurrence rate will be compared between three groups | from embryo transfer day up to pregnancy test | Evaluation the effect of recombinant hCG on OHSS occurrence rate will be compared between three groups |
| Secondary | chemical pregnancy rates | 2 weeks after embryo transfer | Evaluation the effect of recombinant hCG on chemical pregnancy rates 2 weeks after embryo transfer |
| Secondary | clinical pregnancy rates | 4 weeks after embryo transfer | Evaluation the effect of recombinant hCG on clinical pregnancy rates 4 weeks after embryo transfer |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 23274511 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01507376
GET https://conductscience.org/api/trials/v1/NCT01507376/registered